Sparta Capital Ltd Total Liabilities
Sparta Capital Ltd total liabilities. Based on the latest financial reports, Sparta Capital Ltd (SAY) has total liabilities worth CA$3.68 Million CAD (≈ $2.66 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See SAY defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Sparta Capital Ltd (2017–2025)
Total liabilities of Sparta Capital Ltd from 2017 to 2025. This chart illustrates how Sparta Capital Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Sparta Capital Ltd to see how much of total assets are deployed in long-term investments.
Sparta Capital Ltd Competitors by Total Liabilities
The table below lists competitors of Sparta Capital Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Card Factory PLC
LSE:CARD
|
UK | GBX318.00 Million |
|
MEMPHASYS LTD
F:IG7
|
Germany | €5.59 Million |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
India | Rs381.79 Million |
|
Adalta Ltd
AU:1AD
|
Australia | AU$2.07 Million |
|
DOREL INDS INC. A
F:DO4C
|
Germany | €823.37 Million |
|
Social Housing REIT plc
LSE:SOHO
|
UK | GBX266.00 Million |
|
South HARZ Potash Ltd
AU:SHP
|
Australia | AU$1.16 Million |
|
Kakel Max AB (publ)
ST:KAKEL
|
Sweden | Skr47.43 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Sparta Capital Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sparta Capital Ltd (SAY) total assets.
Liquidity & Leverage Metrics
Sparta Capital Ltd Total Liabilities Ratios Explained
Sparta Capital Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -28.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sparta Capital Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sparta Capital Ltd (2017–2025)
The table below shows the annual total liabilities of Sparta Capital Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | CA$4.79 Million ≈ $3.47 Million |
+22.83% |
| 2024-09-30 | CA$3.90 Million ≈ $2.82 Million |
+25.56% |
| 2023-09-30 | CA$3.11 Million ≈ $2.25 Million |
-17.77% |
| 2022-09-30 | CA$3.78 Million ≈ $2.73 Million |
+8.75% |
| 2021-09-30 | CA$3.48 Million ≈ $2.51 Million |
-1.58% |
| 2020-09-30 | CA$3.53 Million ≈ $2.55 Million |
-29.68% |
| 2019-09-30 | CA$5.02 Million ≈ $3.63 Million |
-51.19% |
| 2018-09-30 | CA$10.29 Million ≈ $7.44 Million |
+197.73% |
| 2017-09-30 | CA$3.46 Million ≈ $2.50 Million |
-- |
About Sparta Capital Ltd
Sparta Capital Ltd. engages in environmental, energy, and health technologies businesses in Canada. It operates through Electronics Recycling and Safety Products Transactions segments. It engages in electronics recycling and reselling and product development in health care. The company was incorporated in 1988 and is headquartered in Toronto, Canada.